NXgenPort aims to detect early signs of infection in cancer patients before symptoms arise

Meet NXgenPort, a Saint Paul, Minnesota-based startup that’s looking to remotely monitor cancer patients in between doctor visits using a port catheter. NXgenPort, which presented today at TechCrunch Disrupt Startup Battlefield, is building an implantable chemo port that features added sensors and remote connectivity functions. The port combines chemo-port efficacy with sensor technology to measure and remotely monitor early onset of complications by reporting and tracking patient response over the course of their treatment. The goal of the port is to alert physicians to signs of infection, re

リンク元